Monthly Archives: March 2021
First Canadian dose of Biosimilar Adalimumab (Amgevita) administered at Charlton Health!
Charlton Health is proud to announce that the first dose in Canada of the biosimilar adalimumab, known as Amgevita (produced by Amgen), was injected at Charlton Health on February 22, 2021. Five biosimilars of adalimumab were released onto the Canadian market … Continue reading